Melanocyte protein PMEL;gp100
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Disomotide;181477-43-0;Disomotide [USAN:INN];UNII-8028PPX4PM;disomotida;MPS 22;MPS-22;8028PPX4PM;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoic acid;DTXSID50171158;Gp100:209-217(210m) peptide;Gp-100:209-217(210m) peptide;(186-L-Methionine)melanocyte protein Pmel 17 (human melanoma-associated ME20 antigen)-(185-193)-peptide;L-Valine, L-isoleucyl-L-methionyl-L-alpha-aspartyl-L-glutaminyl-L-valyl-L-prolyl-L- phenylalanyl-L-seryl-;Disomotide [USAN];disomotidum;DISOMOTIDE [INN];DISOMOTIDE [WHO-DD];CHEMBL263429;DTXCID4093649;BDBM50409410;FM109412;HY-105039;Q27269103;H-Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val-OH; H-IMDQVPFSV-OH;(Met186)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) trifluoroacetate salt;L-VALINE, L-ISOLEUCYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-L-GLUTAMINYL-L-VALYL-L-PROLYL-L-PHENYLALANYL-L-SERYL-;L-VALINE, L-ISOLEUCYL-L-METHIONYL-L-ALPHA-ASPARTYL-L-GLUTAMINYL-L-VALYL-L-PROLYL-L-PHENYLALANYL-L-SERYL-; |
M.F/Formula | C47H74N10O14S |
M.W/Mr. | 1035.2 |
Sequence | One Letter Code:IMDQVPFSV Three Letter Code:H-Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val-OH |
Areas of Interest | Antigen-presenting Cells; Cancer Research |
Source# | Homo sapiens (human) |
Epitope | 209-217 |
Restricting HLA | HLA-A2 |
InChI | InChI=1S/C47H74N10O14S/c1-8-26(6)36(49)45(68)51-29(18-20-72-7)39(62)52-31(22-35(60)61)42(65)50-28(16-17-34(48)59)40(63)55-37(24(2)3)46(69)57-19-12-15-33(57)44(67)53-30(21-27-13-10-9-11-14-27)41(64)54-32(23-58)43(66)56-38(25(4)5)47(70)71/h9-11,13-14,24-26,28-33,36-38,58H,8,12,15-23,49H2,1-7H3,(H2,48,59)(H,50,65)(H,51,68)(H,52,62)(H,53,67)(H,54,64)(H,55,63)(H,56,66)(H,60,61)(H,70,71)/t26-,28-,29-,30-,31-,32-,33-,36-,37-,38-/m0/s1 |
InChI Key | BDQMCYCLZBSYJZ-BBXCZNCNSA-N |
References | Kfir Oved; Cancer Immunol Immunother 2005 |
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.